Joincare Pharmaceutical Group Industry Co Ltd (600380.SS)
19 Mar 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|52||2005||Chairman of the Board|
|45||Vice Chairman of the Board|
|54||2006||Finance Director, Deputy General Manager, Director|
|43||2015||Deputy General Manager, Secretary of the Board, Director|
- CORRECTED-BRIEF-Livzon Pharmaceutical Unit's JV Livzon Biologics' Capital Will Be Boosted By 600 Mln Yuan (Feb 7)
- BRIEF-Joincare Pharmaceutical Group's Unit To Invest $10 Mln In Investment Fund Pantheond
- BRIEF-Joincare Pharmaceutical Expects 2017 Net Profit To Rise 362.5-383.9 Percent Y/Y
- BRIEF-Joincare Pharmaceutical Group Industry and units receive subsidy of 217.6 mln yuan
- BRIEF-Joincare Pharmaceutical gets regulatory approval for share placement